Camp4 Therapeutics Corp. Share Price Today: Live Updates & Key Insights

Camp4 Therapeutics Corp. share price today is $4.93, up -3.1%. The stock opened at $5 against the previous close of $5.16, with an intraday high of $5.1 and low of $4.87.

Camp4 Therapeutics Corp. Share Price Chart

Camp4 Therapeutics Corp.

us-stock
To Invest in {{usstockname}}
us-stock

Camp4 Therapeutics Corp. Share Price Performance

$4.93 -0.031(-3.1%) CAMP at 23 Mar 2026 12:22 PM Biotechnology
Lowest Today 4.87
Highest Today 5.1
Today’s Open 5
Prev. Close 5.16
52 Week High 7.75
52 Week Low 1.31
Day’s Range: Low 4.87 High 5.1
52-Week Range: Low 1.31 High 7.75
1 day return -
1 Week return -9.87
1 month return +9.07
3 month return -18.37
6 month return +78.3
1 year return -0.4
3 year return -
5 year return -
10 year return -

Camp4 Therapeutics Corp. Institutional Holdings

Camp4 Therapeutics Corp. Market Status

Strong Buy: 3

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Camp4 Therapeutics Corp. Fundamentals

Market Cap 259.41 M

PB Ratio 4.572

PE Ratio 0.0

Enterprise Value 198.80 M

Total Assets 117.81 M

Volume 372843

Camp4 Therapeutics Corp. Company Financials

Annual Revenue FY23:294949000 294.9M, FY22:295839000 295.8M, FY21:308587000 308.6M, FY20:366107000 366.1M, FY19:363800000 363.8M

Annual Profit FY23:109011000 109.0M, FY22:121886000 121.9M, FY21:122405000 122.4M, FY20:143303000 143.3M, FY19:147764000 147.8M

Annual Net worth FY23:-32490000 -32.5M, FY22:-31148000 -31.1M, FY21:-21157000 -21.2M, FY20:-78774000 -78.8M, FY19:18398000 18.4M

Quarterly Revenue Q3/2025:795000 0.8M, Q2/2025:1497000 1.5M, Q1/2025:858000 0.9M, Q3/2024:0 0.0M, Q4/2023:53625000 53.6M

Quarterly Profit Q3/2025:379000 0.4M, Q2/2025:1497000 1.5M, Q1/2025:858000 0.9M, Q3/2024:null 0.0M, Q4/2023:17574000 17.6M

Quarterly Net worth Q3/2025:-15099000 -15.1M, Q2/2025:-12587000 -12.6M, Q1/2025:-12433000 -12.4M, Q3/2024:-13484000 -13.5M, Q4/2023:-85004000 -85.0M

About Camp4 Therapeutics Corp. & investment objective

Company Information Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Organisation Biotechnology

Employees 48

Industry Biotechnology

CEO Mr. Joshua Mandel-Brehm

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Camp4 Therapeutics Corp. FAQs

What is the share price of Camp4 Therapeutics Corp. today?

The current share price of Camp4 Therapeutics Corp. is $4.93.

Can I buy Camp4 Therapeutics Corp. shares in India?

Yes, Indian investors can buy Camp4 Therapeutics Corp. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Camp4 Therapeutics Corp. shares in India?

You can easily invest in Camp4 Therapeutics Corp. shares from India by:

Can I buy fractional shares of Camp4 Therapeutics Corp.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Camp4 Therapeutics Corp.?

Camp4 Therapeutics Corp. has a market cap of $259.41 M.

In which sector does Camp4 Therapeutics Corp. belong?

Camp4 Therapeutics Corp. operates in the Biotechnology sector.

What documents are required to invest in Camp4 Therapeutics Corp. stocks?

To invest, you typically need:

What is the PE and PB ratio of Camp4 Therapeutics Corp.?

The PE ratio of Camp4 Therapeutics Corp. is N/A and the PB ratio is 4.57.